MyAverix Finance
US · Healthcare
Polaryx Therapeutics, Inc. Common Stock (PLYX)
Biotechnology
Polaryx Therapeutics, Inc. Common Stock (PLYX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PLYX
Polaryx Therapeutics, Inc. Common Stock (PLYX) — FAQ
What is PLYX's P/E ratio?
The price-to-earnings (P/E) ratio for Polaryx Therapeutics, Inc. Common Stock (PLYX) is 18.00 (data as of 2026-03-24).
Does Polaryx Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Polaryx Therapeutics, Inc. Common Stock (PLYX). Check the MyAverix Finance app for the latest dividend data.
What sector is Polaryx Therapeutics, Inc. Common Stock in?
Polaryx Therapeutics, Inc. Common Stock (PLYX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PLYX listed on?
PLYX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.